US and China IP experts call for reforms to boost Chinese pharmaceutical industry
The US-China IP Cooperation Dialogue Report says that greater protection for innovators is needed to unleash the potential of China's pharmaceutical industry
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: